Cleared Special

K252810 - FloPatch FP120

K252810 is an FDA 510(k) clearance for FloPatch FP120, manufactured by Flosonics Medical. The device is a Class 2 Cardiovascular device with product code DPW cleared through the Special 510(k) pathway after a 233-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2026
Decision
233d
Days
Class 2
Risk

K252810 is an FDA 510(k) clearance for the FloPatch FP120. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Flosonics Medical (Toronto, CA). The FDA issued a Cleared decision on April 24, 2026 after a review of 233 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Flosonics Medical devices

FDA 510(k) Submission Details - K252810

510(k) Number K252810 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 2025
Decision Date April 24, 2026
Days to Decision 233 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
108d slower than avg
Panel avg: 125d · This submission: 233d
Pathway characteristics
Modification to existing cleared device.

DPW Device Classification - Class 2, Special Controls

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 78
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K252810.
BlueDop Vascular Expert
K260700 · BlueDop Medical, Ltd. · Jul 2026
VascuChek Kit, VascuChek Transceiver, VascuChek Clinical Probe, VascuChek Speaker Dock (VC-KIT-02, VC-TRX-02, VC-CP-01, VC-SD-01)
K251904 · Remington Medical, Inc. · Nov 2025
FloPatch FP120
K251114 · Flosonics Medical · Jun 2025
Elfor-L
K243852 · Elfi-Tech , Ltd. · Apr 2025
VascuChek Kit, VascuChek Transceiver, VascuChek Clinical Probe, VascuChek Charger (VC-KIT-01, VC-TRX-01, VC-CP-01, VC-CH-01)
K241583 · Remington Medical, Inc. · Aug 2024
FloPatch FP120
K223843 · Flosonics Medical · May 2023